Giulia Bandini, Corrado Campochiaro, Gabriele Ciuti, Domenico Baccellieri, Vincenzo Ardita, Silvia Bellando Randone, Khadija El Aoufy, Dilia Giuggioli, Martina Orlandi, Lorenzo Dagna, Roberto Chiesa, Marco Matucci Cerinic, Alberto Moggi Pignone
{"title":"Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients.","authors":"Giulia Bandini, Corrado Campochiaro, Gabriele Ciuti, Domenico Baccellieri, Vincenzo Ardita, Silvia Bellando Randone, Khadija El Aoufy, Dilia Giuggioli, Martina Orlandi, Lorenzo Dagna, Roberto Chiesa, Marco Matucci Cerinic, Alberto Moggi Pignone","doi":"10.1016/j.ejim.2025.03.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Systemic sclerosis (SSc) is characterized by macro and microvasculopathy, including splanchnic circulation. Chronic mesenteric ischemia (CMI) is a potentially severe condition which can complicate SSc gastrointestinal vasculopathy. Doppler ultrasound (DUS) may be a non-invasive procedure for identifying CMI in symptomatic SSc patients.</p><p><strong>Objectives: </strong>To investigate the capacity of DUS to detect early CMI and the effect of the endovascular approach on CMI-related symptoms.</p><p><strong>Methods: </strong>DUS of splanchnic arteries was performed in symptomatic SSc patients, during routinary outpatient visits.</p><p><strong>Results: </strong>In 6 out of 72 SSc symptomatic patients, DUS suggested a splanchnic vessels stenosis which was confirmed by computed tomography angiography (CTA). After multidisciplinary evaluation in 3 patients a revascularization was performed. Three-monthly clinical and DUS follow-up was negative in all patients.</p><p><strong>Conclusion: </strong>CDU is a useful screening tool for CMI in SSc patients. Revascularization of stenotic mesenteric arteries seems to be a safe and effective procedure.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejim.2025.03.019","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Systemic sclerosis (SSc) is characterized by macro and microvasculopathy, including splanchnic circulation. Chronic mesenteric ischemia (CMI) is a potentially severe condition which can complicate SSc gastrointestinal vasculopathy. Doppler ultrasound (DUS) may be a non-invasive procedure for identifying CMI in symptomatic SSc patients.
Objectives: To investigate the capacity of DUS to detect early CMI and the effect of the endovascular approach on CMI-related symptoms.
Methods: DUS of splanchnic arteries was performed in symptomatic SSc patients, during routinary outpatient visits.
Results: In 6 out of 72 SSc symptomatic patients, DUS suggested a splanchnic vessels stenosis which was confirmed by computed tomography angiography (CTA). After multidisciplinary evaluation in 3 patients a revascularization was performed. Three-monthly clinical and DUS follow-up was negative in all patients.
Conclusion: CDU is a useful screening tool for CMI in SSc patients. Revascularization of stenotic mesenteric arteries seems to be a safe and effective procedure.
期刊介绍:
The European Journal of Internal Medicine serves as the official journal of the European Federation of Internal Medicine and is the primary scientific reference for European academic and non-academic internists. It is dedicated to advancing science and practice in internal medicine across Europe. The journal publishes original articles, editorials, reviews, internal medicine flashcards, and other relevant information in the field. Both translational medicine and clinical studies are emphasized. EJIM aspires to be a leading platform for excellent clinical studies, with a focus on enhancing the quality of healthcare in European hospitals.